U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C23H25FN4O2
Molecular Weight 408.4686
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of 1-(2-(4-(6-FLUORO-1,2-BENZOXAZOL-3-YL)-1-PIPERIDYL)ETHYL)-3-PHENYL-IMIDAZOLIDIN-2-ONE

SMILES

FC1=CC2=C(C=C1)C(=NO2)C3CCN(CCN4CCN(C4=O)C5=CC=CC=C5)CC3

InChI

InChIKey=ULCAXFRFGIKHRG-UHFFFAOYSA-N
InChI=1S/C23H25FN4O2/c24-18-6-7-20-21(16-18)30-25-22(20)17-8-10-26(11-9-17)12-13-27-14-15-28(23(27)29)19-4-2-1-3-5-19/h1-7,16-17H,8-15H2

HIDE SMILES / InChI

Molecular Formula C23H25FN4O2
Molecular Weight 408.4686
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Approval Year

PubMed

PubMed

TitleDatePubMed
Antagonism by haloperidol and its metabolites of mechanical hypersensitivity induced by intraplantar capsaicin in mice: role of sigma-1 receptors.
2009-07
Patents
Substance Class Chemical
Created
by admin
on Mon Mar 31 20:53:49 GMT 2025
Edited
by admin
on Mon Mar 31 20:53:49 GMT 2025
Record UNII
879Y6TC7CG
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
S-18327
Preferred Name English
1-(2-(4-(6-FLUORO-1,2-BENZOXAZOL-3-YL)-1-PIPERIDYL)ETHYL)-3-PHENYL-IMIDAZOLIDIN-2-ONE
Systematic Name English
S18327
Code English
2-IMIDAZOLIDINONE, 1-(2-(4-(6-FLUORO-1,2-BENZISOXAZOL-3-YL)-1-PIPERIDINYL)ETHYL)-3-PHENYL-
Systematic Name English
Code System Code Type Description
FDA UNII
879Y6TC7CG
Created by admin on Mon Mar 31 20:53:49 GMT 2025 , Edited by admin on Mon Mar 31 20:53:49 GMT 2025
PRIMARY
PUBCHEM
9953269
Created by admin on Mon Mar 31 20:53:49 GMT 2025 , Edited by admin on Mon Mar 31 20:53:49 GMT 2025
PRIMARY
CAS
200398-40-9
Created by admin on Mon Mar 31 20:53:49 GMT 2025 , Edited by admin on Mon Mar 31 20:53:49 GMT 2025
PRIMARY
EPA CompTox
DTXSID30433286
Created by admin on Mon Mar 31 20:53:49 GMT 2025 , Edited by admin on Mon Mar 31 20:53:49 GMT 2025
PRIMARY
Related Record Type Details
ACTIVE MOIETY
Relative to the above paradigms, only markedly (>20-fold) higher doses of S18327 were active in models predictive of potential extrapyramidal side effects: induction of catalepsy and prolactin secretion, and inhibition of methylphenidate-induced gnawing in rats.